Which Macrolide Antibiotics Provide Greatest Barrier to Resistance in Streptococcus pneumoniae?

Which Macrolide Antibiotics Provide Greatest Barrier to Resistance in Streptococcus pneumoniae?

0:00

Joseph Blondeau Antibiotic resistance is not going to go away in a hurry, but can we at least make it as difficult as possible for bacteria to overcome the drugs they face? Joseph Blondeau told the co

Joseph Blondeau

Joseph Blondeau

Antibiotic resistance is not going to go away in a hurry, but can we at least make it as difficult as possible for bacteria to overcome the drugs they face?Joseph Blondeautold the conference about his group’s investigation into which of three macrolide antibiotics was the most difficult for Streptococcus pneumoniae to develop resistance against.

Click here for all the interviews from ICAAC 2005

Related Episodes

BORIS: A. baumanni Highly Resistant β-Lactamase and Varying Susceptibility Patterns

BORIS: A. baumanni Highly Resistant β-Lactamase and Varying Susceptibility Patterns

Jennifer Lavrrar, Jane Hata, Jeanette Block REFERENCE: Slide Session C2-1360, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 JANE HATA, bioMéríeu

Entecavir Shows Activity Against HIV But Also Selects for an Antiretroviral Drug Resistance Mutation

Entecavir Shows Activity Against HIV But Also Selects for an Antiretroviral Drug Resistance Mutation

CHLOE THIO, Johns Hopkins University School of Medicine REFERENCE: Abstract: 136LB, 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles February 25-28, 2007 Entecavir, used to tr